טוען...
Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies
INTRODUCTION: The emergence of drug resistance and cross-resistance to existing drugs has warranted the development of new antivirals for Herpes simplex viruses (HSV). Hence, we have designed this study to evaluate the anti-viral activity of 1-[(2-methyl benzimidazole-1-yl) methyl]-2-oxo-indolin-3-y...
שמור ב:
| הוצא לאור ב: | Virol J |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157732/ https://ncbi.nlm.nih.gov/pubmed/34039377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-021-01581-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|